A world-first clinical trial is offering hope to the many Australians suffering chronic back and neck pain. A cannabis oil is achieving positive results for patients with few other options.
Cybis Cannabis Oil Trial Shows Promising Results for Australians with Back and Neck Pain
In a groundbreaking clinical trial, Cybis cannabis oil has shown promising results in providing relief to Australians suffering from chronic back and neck pain. This development comes as a beacon of hope for the many battling these conditions daily.
The clinical trial, is a non-randomised, single-arm, open-label study involving participants with chronic back or neck pain. The encouraging results have been hailed by medical professionals and patients alike.
Cymra Life Sciences, the company behind Cybis oil, reported positive results from their phase II trial. This trial tested the efficacy of Cybis oil on patients dealing with chronic neck and back pain. The results add to mounting evidence supporting the use of CBD and THC in managing chronic spine pain and curbing opioid-related risks.
As per the details available, the trial demonstrated that doses of Cybis were well-tolerated by patients with chronic neck/back pain. It also showed that CBD and Δ9-THC could effectively manage pain in these patients. With the introduction of over-the-counter CBD oil in Australia in early 2021, this development marks a significant step forward in pain management.
The trial’s success is a testament to the potential of cannabis oil in offering a viable alternative treatment for chronic pain sufferers. It also underscores the necessity of continued research into the therapeutic properties of cannabis.
With this breakthrough, Cybis cannabis oil could soon become a staple in the homes of Australians seeking relief from chronic back and neck pain. As further trials continue, the future looks promising for those who have long sought an effective, affordable solution to managing their pain.
